ADIL Research and Charts

ADIL - Adial Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-01-03)

Last 1.09	Change ⇑ +0.02 (+1.87%)	Volume 75,972
	Open 1.07	High 1.10	Low 1.05

8EMA (Daily) 1.06	40EMA (Daily) 1.06	50EMA (Daily) 1.06	STO (Daily) 30.340	MACD Hist (Daily) -0.005
8EMA (Weekly) 1.064	40EMA (Weekly) 1.17	50EMA (Weekly) 1.21	STO (Weekly) 42.778	MACD Hist (Weekly) 0.040


Company Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.